Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more
We believe that cancer therapy should be as unique as you are. Our innovative approach to therapies represents a fundamental shift from one-size-fits-all treatments to precision medicine that recognizes the distinct genetic and biological characteristics of each patient and their cancer.
Through cutting-edge science and personalized medicine, we're pioneering new therapies for treating cancer that offer hope, healing, and improved outcomes for patients worldwide.
Traditional cancer treatments often rely on broad-spectrum approaches that may not account for the unique biological fingerprint of a patient’s specific cancer. Our precision approach to cancer therapy treatment changes this paradigm entirely. By analyzing an individual cancer's unique genetic profile, cellular behavior, and individual biological markers, we’re able to develop targeted treatments that work with the body's natural healing mechanisms rather than against them.
This personalized methodology is part of a new wave of advancements for therapies in cancer that goes beyond conventional treatment protocols. We understand that cancer is not just one disease - it's hundreds of different diseases that require individualized approaches.
Our approach begins with comprehensive testing that reveals the molecular and genetic landscape of a patient’s cancer. Using advanced liquid biopsy technology and circulating tumor cell (CTC) analysis, we gather crucial information about how the cancer behaves, what drives its growth, and which therapeutic approaches are most likely to be effective.
This detailed biological understanding forms the foundation of our personalized cancer therapies. Rather than relying on general treatment protocols, RGCC-certified Practitioners can create individualized therapy recommendations based on a cancer's specific vulnerabilities and the body's unique response patterns.
This precision approach maximizes therapeutic effectiveness while minimizing unnecessary side effects.
Our cancer treatment therapies include cutting-edge autologous therapies that are at the forefront of personalized cancer care. These sophisticated therapeutic interventions work by harnessing your body's own immune system and cellular mechanisms to target cancer cells with unprecedented precision.
Personalized therapies are a new cancer therapy treatment approach that moves beyond traditional methods by utilizing living cells, or oligonucleotides. These therapies are manufactured specifically for each patient, ensuring optimal compatibility and effectiveness. Our state-of-the-art facilities and rigorous quality control processes ensure that each therapeutic product meets the highest standards of safety and efficacy.
Q-REstrain is a personalized cancer treatment that uses microRNAs isolated from the patient's own circulating tumor cells to target and silence genes that are overactive in their specific cancer. This precision approach harnesses the body's natural RNA interference process to reduce the production of proteins that fuel cancer growth. Available exclusively for autologous use through the RGCC network, Q-REstrain is an innovative, patient-specific therapeutic strategy.
Clavic-Q-RE is a sophisticated therapy that combines personalized immune cell therapy with targeted molecular interventions. This new therapy for treating cancer is designed to work with the body's natural defense mechanisms while directly targeting cancer cells through multiple pathways.
This therapy offers improved treatment specificity, enhanced therapeutic effectiveness, and reduced systemic side effects compared to conventional treatments. Clavic-Q-RE is part of a movement in cancer therapy toward more precisely tailored and effective interventions.
Vaccine Prep (ATA) is a personalized cancer immunotherapy that trains the patient's immune system to recognize and attack their specific cancer. This innovative treatment uses cellular fragments from the patient's own circulating tumor cells (CTCs)—including proteins, genetic material, and cellular components—to create a personalized cancer vaccine. By exposing the immune system to these tumor-specific markers, Vaccine Prep strengthens the body's natural ability to identify and destroy cancer cells that share these characteristics.
Dendritic Cell Therapy is an advanced cancer treatment therapy that utilizes the body's antigen-presenting cells to educate one’s own immune system about cancer. This personalized therapy for treating cancer enhances the natural immune response by using dendritic cells, activated against patient's specific peptides to further activate immune cells.
This therapy provides enhanced immune training, improved cancer cell recognition, and sustained anti-cancer immune response. Dendritic Cell Therapy is a breakthrough in personalized cancer therapies that leverages the power of your own immune system.
Healthcare practitioners seeking to expand their cancer therapy options will find RGCC's personalized approach invaluable for their patients. Our comprehensive testing and therapeutic protocols provide detailed insights that enable more informed treatment decisions and improved patient outcomes.
We offer extensive training and support to help practitioners integrate these advanced therapies into their practice. Our scientific team provides ongoing consultation and guidance to ensure optimal implementation of our personalized cancer treatment therapy protocols.
Patients and families looking for hope beyond traditional treatments will find that our advanced personalized medicine approaches offer renewed optimism and improved possibilities for recovery. Our personalized cancer therapy treatment options are designed for individuals who want to take an active role in their healing journey.
Our commitment to scientific excellence drives everything we do. We invest continuously in research and development to advance the field of personalized cancer therapy. Our laboratories utilize the most sophisticated testing methodologies available, ensuring that our cancer therapies are based on the most current scientific understanding.
We collaborate with leading researchers and institutions worldwide to stay at the forefront of cancer treatment innovation. This dedication to scientific advancement ensures that our patients have access to the most effective new therapy for treating cancer options available.
We don't believe in one-size-fits-all approaches to cancer care. Instead, our therapies for cancer help practitioners create protocols tailored specifically to each patient's cancer characteristics and individual health profile.
Our precision approach extends beyond just therapy selection. We also comprehensive blood-based cancer testing options that support personalized medicine at every stage of the cancer journey.
Discover how our innovative cancer therapy approaches can provide hope and healing for patients and their loved ones. Contact us today to learn more about our personalized therapies and how a new therapy for cancer may make all the difference. Take the first step toward a more targeted, effective treatment journey.
Explore our curated collection of videos, providing an in-depth look at our innovative solutions and groundbreaking research.
In this insightful interview from the 2023 RGCC Gathering, Dr. Clayton Bell shares his journey of integrating RGCC technologies into his practice in the U.S.
With a background in Functional, Environmental, and Integrative Medicine, Dr. Bell reveals how he uses RGCC’s cutting-edge cancer diagnostics and therapies to support his patients’ healing. Watch the full video to learn more.
Helena Pöhlmann who specializes in holistic medicine shares how she utilizes RGCC products in her clinic to best support her patients. Watch the video to learn about her experience at the 2023 RGCC Gathering in Switzerland.
Cancer survivor and RGCC Practitioner, Jenny Hrbaceck, discusses RGCC testing and the impact it has made on her life.
Watch an interview with Dr. Bita Badakhshan, a seasoned practitioner in primary family medicine with over 12 years of experience in integrative oncology and functional medicine.
In this video, Dr. Bita shares her experience with RGCC’s transformative liquid biopsy testing. She highlights the unparalleled precision and detail offered by RGCC's advanced methodologies over other laboratories.
Dr. Bita emphasizes the unmatched sensitivity of RGCC's testing, which delves deep into analyzing stem cells, cancer cells, and a comprehensive array of markers crucial for personalized cancer care.
Since 2012, Dr. Beta has trusted RGCC for blood testing on patients, particularly focusing on circulating tumor cell analysis and using RGCC’s Oncocount and Oncotrace tests along with the Onconomics Plus assessments.
Through RGCC's innovative tests and therapies, Dr. Bita has been able to make informed decisions sparing many patients from unnecessary chemotherapy and radiation post-tumor removal surgeries.
Join host Sam Tejada for an essential conversation about cancer innovation and breakthroughs on this episode of A Healthy Point of View, including a close look at advances in early cancer detection - as early as stage ZERO.
Tejada sits down with two leading medical experts: Dr. Christopher Davis, an interventional cardiologist and CMO of Liquivida, and Dr. Ioannis Papasotiriou, MD, PhD, SCym, the founder of RGCC.
Together, they tackle one of medicine's most complex challenges, sharing cutting-edge insights and breakthrough approaches that could transform how we understand and address cancer care.
Explore our curated collection of videos, providing an in-depth look at our innovative solutions and groundbreaking research.
In this insightful interview from the 2023 RGCC Gathering, Dr. Clayton Bell shares his journey of integrating RGCC technologies into his practice in the U.S.
With a background in Functional, Environmental, and Integrative Medicine, Dr. Bell reveals how he uses RGCC’s cutting-edge cancer diagnostics and therapies to support his patients’ healing. Watch the full video to learn more.
Helena Pöhlmann who specializes in holistic medicine shares how she utilizes RGCC products in her clinic to best support her patients. Watch the video to learn about her experience at the 2023 RGCC Gathering in Switzerland.
Cancer survivor and RGCC Practitioner, Jenny Hrbaceck, discusses RGCC testing and the impact it has made on her life.
Watch an interview with Dr. Bita Badakhshan, a seasoned practitioner in primary family medicine with over 12 years of experience in integrative oncology and functional medicine.
In this video, Dr. Bita shares her experience with RGCC’s transformative liquid biopsy testing. She highlights the unparalleled precision and detail offered by RGCC's advanced methodologies over other laboratories.
Dr. Bita emphasizes the unmatched sensitivity of RGCC's testing, which delves deep into analyzing stem cells, cancer cells, and a comprehensive array of markers crucial for personalized cancer care.
Since 2012, Dr. Beta has trusted RGCC for blood testing on patients, particularly focusing on circulating tumor cell analysis and using RGCC’s OncoCount and OncoTrace tests along with the Onconomics Plus assessments.
Through RGCC's innovative tests and therapies, Dr. Bita has been able to make informed decisions sparing many patients from unnecessary chemotherapy and radiation post-tumor removal surgeries.
Read more about our therapies on our website: https://rgcc-international.com/rgcc-therapies/
RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou who believes that the key to effectively treating cancer lies in personalized medicine using the information in a patient’s genes.
Individualized treatment for cancer is the focus behind RGCC’s testing protocols and advanced therapy options. Our slate of tests analyzes the state of a person’s cancer by looking at the cellular and genetic makeup of each patient. Our test results give you information that acts as a blueprint for what treatment protocols are likely to show the most efficacy for your specific biology.
Learn more about RGCC at
https://rgcc-international.com/
Follow us on social media to find out the latest news and updates from our experts.
Facebook: https://www.facebook.com/profile.php?id=61554630098937
Instagram: https://www.instagram.com/rgcc_north_america/
LinkedIn: https://www.linkedin.com/company/r-g-c-c-international-gmbh/
Join host Sam Tejada for an essential conversation about cancer innovation and breakthroughs on this episode of A Healthy Point of View, including a close look at advances in early cancer detection - as early as stage ZERO.
Tejada sits down with two leading medical experts: Dr. Christopher Davis, an interventional cardiologist and CMO of Liquivida, and Dr. Ioannis Papasotiriou, MD, PhD, SCym, the founder of RGCC.
Together, they tackle one of medicine's most complex challenges, sharing cutting-edge insights and breakthrough approaches that could transform how we understand and address cancer care.
